
ã¯ã©ãªãã€ãåŒçšæ èªè³ïŒçµæžïŒã·ãªãŒãºèšäºïœãžã§ã·ã¥ã¢ã»ã¢ã³ã°ãªã¹ã
第 1 ç« åºâäžçãæ³šç®ãããçµæžåŠã®é è³ã
ãžã§ã·ã¥ã¢ã»ã¢ã³ã°ãªã¹ãã¯ãèªç¶å®éšïŒnatural experimentsïŒãçšããŠå æå¹æãèå¥ããããã¶ã€ã³åèšéçµæžåŠãã確ç«ããç ç©¶è
ã§ãããã©ã³ãã åã«è¿ãå¶åºŠã®âãããâãæãããã«ãæè²ã»åŽåã»æ¿çã®å æå¹æãæ£é¢ããæšãéãã
èšéææ³ïŒIVã»RDDã»DIDïŒãã䜿ããéå
·ãã«éãäžããå®éã®ç€ŸäŒèª²é¡ãžæ©æž¡ãããåçžŸã¯æ±ºå®çã ãåŠæŽã®å æå¹æã城å
µã»æŠäºã®åçãžã®åœ±é¿ãåŠçŽèŠæš¡ã®å¹æããã£ãŒã¿ãŒã¹ã¯ãŒã«ã®æå¹æ§ãªã©ãæ¿çè«äºã®æ žå¿ã«ããåãã«ãèå¥âæšå®âè§£éã®äžè²«æé  ã§çãã瀺ããŠããã
2021 幎ãããããã»ã«ãŒããã°ã€ãã»ã€ã³ãã³ã¹ãšãšãã«ããŒãã«çµæžåŠè³ãåè³ã
ãå æã¯èšèšããå§ãŸããââããã圌ã®çµæžåŠã®åèšèã§ããã
第 2 ç« åç¹âå¹Œå°æãšåŠåã®åºçºç¹
1960 幎çãŸããè¥ææããæè²ã®åççãåŽååžå Žã®å æå¹æã«é¢å¿ãæã¡ãå¶åºŠãçãå¶ç¶æ§ã«æ³šç®ããã倧åŠã»å€§åŠé¢ã§ã¯ãå
çæ§ïŒendogeneityïŒã®å£ãä¹ãè¶ããããã«ãããŒã«å€æ°ïŒIVïŒãæç¹ååž°ïŒRDDïŒã®èšèšææ³ã磚ãäžããã
ãããŠãèªçæã®éãã城å
µæœéžãåŠçŽç·šå¶ã«ãŒã«ãå
¥åŠæœéžãšãã£ãèªç¶çºççãªâæºã©ã³ãã âãã€ããŸããçŸå®ã®æ¿çãšå ææšè«ãçŽçµãããã¹ã¿ã€ã«ãåºãããåŸå¹Žã¯æè²çµæžåŠã®çŸå ŽãšåŸåŸ©ããåŠæ ¡éžæã»ãã£ãŒã¿ãŒã¹ã¯ãŒã«ã»è·æ¥èšç·Žãªã©ã®å®èšŒã«åãæ³šãã ã
第 3 ç« æ žå¿âç ç©¶ã®äžæ žçè«ãšäž»åŒµ
(1) ããŒã«å€æ°ïŒIVïŒãš LATEïŒå±æå¹³ååŠçœ®å¹æ
ã¢ã³ã°ãªã¹ãã¯ãã°ã€ãã»ã€ã³ãã³ã¹ããšãšãã« LATEïŒLocal Average Treatment EffectïŒã®æ çµã¿ãæç€ºããIV æšå®å€ããã³ã³ãã©ã€ã€ãŒïŒéå
·ã«åå¿ããŠåŠçœ®ãå€ãã人ãã¡ïŒãã«å¯Ÿããå¹³å广ãèå¥ããããšãæç€ºãããããã§éèŠãªã®ã¯ãé¢é£æ§ã»å€çæ§ã»å調æ§ãšããäžæ¡ä»¶ã§ããã
é¢é£æ§ïŒéå
·ãåŠçœ®ã«ååå¹ãããš
å€çæ§ïŒéå
·ãã¢ãŠãã«ã ãžçŽæ¥ã¯å¹ããªãããš
å調æ§ïŒéå
·ãåŠçœ®ãéåãã«åããã¿ã€ããããªãããš
ãã®éæãªè§£éã¯ãIVïŒéæ³ã®ç®±ãšãã誀解ãæããã誰ãžã®å¹æãããæç¢ºã«ããå®åèŠç¯ãšãªã£ãã
(2) æç¹ååž°ïŒRDDïŒãšèŠåã®âå¢ç®â
ã¹ã³ã¢ã幎霢ãå®å¡ãªã©ã«ãŒã«ã®å¢ç®ã«æ³šç®ãããã®ããè¿åã§åŠçœ®å²åœã âã»ãŒã©ã³ãã âã«ãªãäºå®ã掻ãããŠå æå¹æãèå¥ããã®ãRDD ã ãã¢ã³ã°ãªã¹ãã¯æè²ã»åŽåã®çŸå Žã§éãæç¹ïŒsharpïŒã匱ãéµå®ã®æç¹ïŒfuzzyïŒã䜿ãåããããŒã«ã«ãªæ¯èŒã§é å¥ãªæšå®ãè¡ãäœæ³ãæ®åãããã
(3) å·®ã®å·®ïŒDIDïŒãšæ¿çã·ã§ãã¯
å¶åºŠå€æŽãå€çã·ã§ãã¯ã®ååŸå·®ãã察ç
§çŸ€ãšã®å·®ã§ããäžåºŠå·®ãåŒã DIDãã¢ã³ã°ãªã¹ãã¯ãå¹³è¡ãã¬ã³ãä»®å®ã®èšºæãã€ãã³ãã¹ã¿ãã£ã«ããååŠã®å¯èŠåãªã©ãå®åã«èããæ€èšŒæé ã確ç«ãã芳枬ããŒã¿ã§å æãè¿ã¥ããã¹ã¿ã³ããŒããäœã£ãã
(4) ãã¶ã€ã³äž»çŸ©ãšå®åã®æç§æž
ã¢ã³ã°ãªã¹ãã¯çè«å®¶ã§ãããšåæã«æè²è
ã§ãããããçŸå Žã䜿ããèšéãã«åŸ¹ããæšå®åšã®éžæâèå¥ä»®å®âããã¹ãæ§æ€èšŒâå¯èŠåãšããäžé£ã®ã¯ãŒã¯ãããŒããç ç©¶ã»æ¿ çã»äŒæ¥åæã®å
±éèšèªã«ããã
第 4 ç« ææŠâæ¢åçè«ãšã®å¯Ÿç«ãšé©æ°
ãã€ãŠãèšéçµæžåŠã¯åææ¹çšåŒãåŒ·ãæ§é ä»®å®ã«äŸåããã¡ã ã£ããã¢ã³ã°ãªã¹ãã¯ããä»®å®ã¯æ§ããã«ãèšèšã¯æçã«ããšããå§¿å¢ã§è»¢æãè¿«ããå€ççã°ãã€ãã«é Œããã¶ã€ã³ãéèŠãã誰ã«å¯Ÿãã广ãïŒå±ææ§ïŒãæ£é¢ããæç€ºããç¹ã驿°çã ã£ããäžæ¹ã§ãå€çåŠ¥åœæ§ïŒä»æã§ãå¹ããïŒã匱ãéå
·ãæäœå¯èœãªæç¹ãªã©ã®æ¹å€ã«ãåãåã ãåæã®éç€ºã»æåºŠåæã»åçŸå¯èœæ§ãæšæºäœæ³ãšããŠæ ¹ä»ãããã
第 5 ç« æ³¢åâæ¿çã»ç€ŸäŒãžã®åœ±é¿
æè²ïŒèªçæ IV ã«ããåŠæŽã®å æå¹æãåŠçŽèŠæš¡ã®å¹æãå
¥åŠæœéžãå©çšããåŠæ ¡éžæã®è©äŸ¡ãªã©ãå¶åºŠãã¶ã€ã³ã®æ ¹æ ãæç€ºã
åŽåã»ç€ŸäŒä¿éïŒåŸŽå
µæœéžãçšããè»åã®æåŸå¹æãç§»æ°ã»æäœè³éã»è·æ¥èšç·Žãšãã£ãè«ç¹ã§ãè°è«ã®åå°ãå®éåã
å®åã»å
Œ
±éšéïŒæ¿çéšå±ã»æè²å§å¡äŒã»NPO ã§ãå
¥è©Šã»é
åã«ãŒã«ã»è£å©éã®å¹ææ€èšŒã«ãã¶ã€ã³åææ³ãæ®åãã詊ããŠã枬ã£ãŠãçŽãããšãã Evidence-Based Policyã®æåãåºããã
第 6 ç« å±æâçŸåšã®ç ç©¶ãšä»åŸã®èª²é¡
å€çåŠ¥åœæ§ãšç°è³ªæ§ïŒLATE ã®â屿æ§âãè¶
ããŠãã©ã®äººã«ãã©ã®ç°å¢ã§ãã©ãã»ã©å¹ãããå°å³åãéšååè¡¡âäžè¬åè¡¡ãžã®æ¥åã課é¡ã
æ©æ¢°åŠç¿Ãå æïŒããã¹ãã»è¡æ¿ããã°ããŒã¿ãçšãããããå¹æã®æšå®ãæ¿çã¿ãŒã²ãã£ã³ã°ãã¬ããã³ã¹ã®æ¹åããã ãéé©åãšè§£éå¯èœæ§ãžã®é
æ
®ãäžå¯æ¬ ã
èšèšãšå«çïŒæç¹âåšãâã®æ£æãã¢ã«ãŽãªãºã ã«ããéžæã®ãã€ã¢ã¹ãªã©ãæ°ãããã¶ã€ã³ã®å«çç¹æ€ãéææ§ã»åçŸæ§ã»èª¬æè²¬ä»»ãéµã«ãªãã
çŸå Žãšã®å
±åµïŒç ç©¶è
ãšæ¿ççŸå Žãèšè𿮵éããååããå®è£
å¯èœæ§ãšèå¥ã®äž¡ç«ãå³ãâå
±åèšèšâã®æä»£ãžã
第 7 ç« çµ âãæ¬¡ã®ããŒãã«è³ãã«æãè¿ãé è³
ã¢ã³ã°ãªã¹ãã®çµæžåŠã¯ããå ææšè«ã¯æ°åŒã§ã¯ãªãèšèšããå§ãŸãããšãã転æã宿ããããIVã»RDDã»DID ã¯ãæœè±¡çè«ã§ã¯ãªã瀟äŒã枬ãéå
·ã§ããã誰ã«å¹ãã®ããæç€ºããèª å®ããæ žå¿ã«ããã
æè²ã¯äººããå¶åºŠã¯ç€ŸäŒãããããŠæšå®ã¯æææ±ºå®ãå€ãããæ§ãããªä»®å®ã»æå¿«ãªèšèšã»ççŽãªè§£éãšããäžæ¬æ±ã¯ããããããæ¿ççŸå Žãšç ç©¶ã®äž¡æ¹ã§çãç¶ããã ããã
å æã¯ãããèšèšãããäžçã§ãã¯ãããŠèŠããŠããã
ããããã£ãã³ã·ã£ã«ãã¥ãŒã¹
å
¬åŒãµã€ã
https://www.sakurafinancialnews.com/
YouTube
å
¬åŒX